Letroz

Letroz Product Image

Rs.984.81

Letroz

(10 customer reviews)

Letroz, developed by Sun Pharma, contains Letrozole 2.5mg and is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. This medication works by inhibiting the enzyme aromatase, which is responsible for producing estrogen, thereby reducing estrogen levels and preventing the growth of cancer cells.

Brand: Sun Pharma Composition: Letrozole 2.5mg

Product Introduction

Letroz is a highly effective medication for the treatment of breast cancer in postmenopausal women. It works by decreasing estrogen levels, which in turn inhibits the growth of estrogen-dependent breast cancer cells. Developed by Sun Pharma, Letroz has become a standard treatment for patients diagnosed with hormone receptor-positive breast cancer.

Letroz plays a crucial role in adjuvant therapy, as well as in the treatment of advanced breast cancer. It provides an alternative for patients who are unable to tolerate other medications.

Uses of Letroz

Letroz is primarily used for:

Letroz Uses
  • Breast Cancer Treatment – Reduces estrogen production to inhibit cancer cell growth.
  • Hormone Receptor-Positive Breast Cancer – Used in postmenopausal women for estrogen-dependent tumors.
  • Adjuvant Therapy – Part of a combination treatment strategy for early-stage breast cancer.

Letroz supports effective cancer management by targeting the hormonal aspects of tumor growth.

Side Effects of Letroz

Common side effects of Letroz may include:

  • Hot flashes
  • Joint pain
  • Fatigue
  • Nausea
  • Weakness

Less Common Side Effects

Less frequent but more serious side effects may include:

  • Osteoporosis
  • Heart disease
  • High cholesterol
  • Increased risk of bone fractures

We are pleased to offer you this product.

Letroz ensures effective management of hormone receptor-positive breast cancer when used under proper medical supervision. It is a cornerstone treatment for postmenopausal women and offers a reliable option for combating this disease.

  • Take as directed by your healthcare provider, usually once daily.
  • Can be taken with or without food.
  • Do not skip doses to ensure optimal results.

Letroz inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens in postmenopausal women. By lowering estrogen levels, it prevents the growth of hormone receptor-positive breast cancer cells.

  • Effective for hormone receptor-positive breast cancer.
  • Reduces estrogen production to inhibit tumor growth.
  • Proven efficacy in postmenopausal women.
  • Well-tolerated with manageable side effects in most patients.
  • Regular monitoring of bone health is recommended.
  • Avoid excessive alcohol consumption while on treatment.
  • Notify your doctor of any history of heart disease or osteoporosis.

Letroz is an essential part of the fight against hormone receptor-positive breast cancer. Always consult your healthcare provider for personalized advice and treatment options.